AGC
FLACU

Angelo Gordon & Co’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Angelo Gordon & Co’s Portfolio FLACU Stock Details FLACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-25,000
Closed -$260K – 201
2020
Q4 		$260K Buy
+25,000
New +$261K 0.02% 89

Other funds holding FLACU

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Angelo Gordon & Co's FLACU Position: Q1 2021 in Review

Angelo Gordon & Co sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q1 2021, closing a stake of 25,000 shares — an estimated $260K sold.

Angelo Gordon & Co first reported a position in FLACU in Q4 2020 and held it in 1 quarter. The position peaked at $260K in Q4 2020. 37 funds tracked by Wall St. Rank hold FLACU as of Q1 2021.

  • Angelo Gordon & Co reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q1 2021 after selling out during the quarter.
  • Angelo Gordon & Co sold 25,000 Frazier Lifesciences Acquisition Corporation Unit shares in Q1 2021, an estimated $260K.
  • Angelo Gordon & Co first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 1 quarter.
  • Angelo Gordon & Co's Frazier Lifesciences Acquisition Corporation Unit position peaked at $260K in Q4 2020.
  • 37 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q1 2021.

Based on Angelo Gordon & Co's 13F filing for Q1 2021, filed 17 May 2021.